• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Verona Pharma plc - American Depositary Shares (NQ:VRNA)

106.91 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Verona Pharma plc - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves ↗
December 29, 2023
In recent statements to the Financial Times and The Sunday Times, GSK plc (NYSE: GSK) Chief Commercial Officer Luke Miels revealed the company's intent to pursue acquisitions within the $2 billion... 
Via Benzinga
News headline image
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
December 26, 2023
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth... 
Via Benzinga
News headline image
Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal ↗
April 08, 2023
Duality Biologics out-licensed global rights (ex-China) for two ADC candidates to BioNTech, Pfizer’s partner, for one of the two original COVID-19 vaccines in a deal worth $170 million upfront and up... 
Via Talk Markets
News headline image
4 Analysts Have This to Say About Verona Pharma ↗
March 13, 2023
 
Via Benzinga
News headline image
Earnings Preview For Verona Pharma ↗
March 06, 2023
 
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today ↗
December 30, 2022
 
Via Benzinga
News headline image
Earnings Scheduled For November 2, 2023 ↗
November 02, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. 
Via Benzinga
News headline image
Expert Ratings for Verona Pharma ↗
September 01, 2023
 
Via Benzinga
News headline image
Earnings Scheduled For August 3, 2023 ↗
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
News headline image
Earnings Scheduled For May 9, 2023 ↗
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million. 
Via Benzinga
News headline image
Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday ↗
March 20, 2023
HC Wainwright & Co. cut the price target for 89bio, Inc. (NASDAQ: ETNB) from $27 to $25. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. 89bio shares fell 5.2% to trade at $11.80 on... 
Via Benzinga
BTIG Maintains Buy Rating for Verona Pharma: Here's What You Need To Know ↗
December 20, 2022
 
Via Benzinga
News headline image
Top-Notch Verona Pharma Scores A Win In COPD — And Hits A Four-Year High ↗
December 20, 2022
The experimental mist reduced the risk of exacerbations in patients by 36%. 
Via Investor's Business Daily
News headline image
7 Biotech Stocks That Could Be the Next Big Thing ↗
March 15, 2023
Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough. 
Via InvestorPlace
News headline image
PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday ↗
January 03, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Why These 7 Healthcare Stocks Could Soar in 2023 ↗
January 02, 2023
These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023. 
Via InvestorPlace
News headline image
20 Favorite Biotech & Medical Stocks For 2023 ↗
December 28, 2022
The way these stocks are setting up, many of them look great and will be at the forefront this coming year. 
Via Talk Markets
News headline image
Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review ↗
December 23, 2022
The market uptrend is under pressure. 
Via Investor's Business Daily
News headline image
7 Drug Stocks That Will Soar in 2023 ↗
December 22, 2022
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
December 21, 2022
 
Via Benzinga
News headline image
Tesla, Amazon, Nike, FedEx, Verona Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today ↗
December 20, 2022
Major Wall Street indices closed in the green on Tuesday, albeit just marginally higher, ending a four-day losing streak as investors and traders are watching out for a much anticipated year-end rally.... 
Via Benzinga
News headline image
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗
December 20, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
December 20, 2022
 
Via Benzinga
News headline image
SINT Stock Alert: What to Know About Sintx Technologies’ Reverse Stock Split ↗
December 20, 2022
Sintx Technologies (SINT) stock is in the news Tuesday as the company enacted a reverse stock split when markets opened this morning. 
Via InvestorPlace
News headline image
Why Is Verona Pharma (VRNA) Stock Up 34% Today? ↗
December 20, 2022
Verona Pharma (VRNA) stock is rising higher on Tuesday after the company released results from a Phase 3 clinical trial. 
Via InvestorPlace
News headline image
Verona Pharma Stock Garners Investors' Attention After Successful COPD Trial ↗
December 20, 2022
 
Via Benzinga
News headline image
Lucid Is Revving Up, but This Nasdaq Stock Is Jumping Even More ↗
December 20, 2022
Investors hoped for a rebound in the stock market, but they might have to settle for gains in these two stocks. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
December 20, 2022
 
Via Benzinga
News headline image
Lucid Group, Verona Pharma And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
December 20, 2022
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday ↗
December 20, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning! 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap